• About Us
  • Board of Advisors
  • Contact

MALARIA.com

A Malaria Information and Community Portal

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
Home / Malaria Q&A / Do malarial drugs engender joint pains?

Do malarial drugs engender joint pains?

February 24, 2012 By Malaria Q&A Leave a Comment

QUESTION

I am now over 50 and I lived all my life in Africa during which time I have had a considerable incidences of malarial attacks. Each time I took any anti-malarial drug I experienced some side-effects including blurred vision, fatigue and joint pains. The pains especially have since become a permanent part of me and even severe enough to hamper my mobility. Does my condition sound to have any relationship with the several quantity and varieties of anti malarial drugs that I took almost all my life?

ANSWER

There are no known long-term side effects to taking modern anti-malarial drugs. However it could be that you have had a reaction or allergy to the specific kind of anti-malarials you have used in the past. For example, quinine sulphate is associated with joint pain in rare cases. However, in Africa these days, the World Health Organisation recommends only the use of artemisinin-based combination therapies (ACTs, such as Coartem) as the first-line treatment for malaria. The side effects of ACTs tend to be mild, and limited to nausea, dizziness and vomiting. As far as I am aware, joint pain and blurred vision have not been reported as side effects.

We at Malaria.com are very interested in hearing people’s experiences with antimalarial medication, so we would be very grateful if you would take the time to complete a survey on malaria treatment which we are running on the website. Thank you!

Filed Under: Malaria Q&A Tagged With: ACTs, antimalarials, Artemisinin-based Combination Therapies, quinine sulphate, side effects, World Health Organisation

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Informed

WWARN Corner

About WWARN

The WorldWide Antimalarial Resistance Network (WWARN) generates innovative resources and reliable evidence to inform the malaria community on the factors affecting the efficacy of antimalarial medicines. Learn more…

  • Fighting Malaria Requires Protecting the Effectiveness of Antimalarial Medicines
  • Data Sharing at IDDO
  • Evidence to inform equitable dosing in very young and malnourished children

More WWARN Stories...

Five Things You Might Not Know About Medicine Quality

The proliferation of poor quality medicines has been described as a global pandemic that threatens the lives of millions.1 It stands to reason that poor quality medicines are not going to improve anyone’s health, but how much do we really know about the quality of medicines used across the world? Here we examine five issues relating to medicine quality in an effort to show why we should all be paying more attention to a serious public health issue that is difficult to tackle and not yet fully understood.

How Can We Detect Poor Quality Medicines?

Finding out what medicines contain and investigating their packaging are vital steps in the fight against poor quality medicines, both substandard and falsified. Falsified medicines usually masquerade as real medicines by copying the appearance and packaging of the real product, but may not contain any of the same active ingredients, or in the correct amounts.

Challenges in Tackling the Issue of Poor Quality Medicines

There are many unresolved issues that impede the elimination of poor quality medicines, namely: (1) Progress impeded by confusion over definitions; Ensuring a market free of poor quality medicines; and the lack of global criminal laws.

Editorial

Antimicrobial Resistance: The Silent Threat in Malaria Eradication

By Bernard Owusu Agyware, Arielle Dolegui and Jesus Aquilar Malaria is a serious and sometimes deadly disease, affecting millions and claiming more than  600,000 lives worldwide each year in 2022 and 2021.1 Low and Middle-Income Countries (LMICs), particularly in Sub-Saharan Africa, disproportionately bear the greatest burden of malaria. The fight to eradicate this worrisome disease […]

  • Home
  • Malaria Overview
  • Malaria Research
  • News
  • Videos
  • Blogs
  • Malaria Q&A
  • Events
  • Jobs
  • About Us
  • Board of Advisors
  • Contact

Copyright © 2026 Malaria.com · Log in